DUSP5 and thyroid gland carcinoma: Using two BRAFV600E thyroid carcinoma cell lines (BCPAP and 8505c), the same authors showed that genetic inhibition of DUSP5 and DUSP6 did not affect cell proliferation or ERK1/2 phosphorylation, while reducing cell migration and invasion [146].